TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.110
+0.020 (1.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
TherapeuticsMD Revenue
TherapeuticsMD had revenue of $547.00K in the quarter ending September 30, 2024, a decrease of -1,132.08%. This brings the company's revenue in the last twelve months to $1.60M, down -97.70% year-over-year. In the year 2023, TherapeuticsMD had annual revenue of $1.30M, down -98.14%.
Revenue (ttm)
$1.60M
Revenue Growth
-97.70%
P/S Ratio
7.94
Revenue / Employee
$1,596,000
Employees
1
Market Cap
12.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.30M | -68.66M | -98.14% |
Dec 31, 2022 | 69.96M | 67.39M | 2,619.12% |
Dec 31, 2021 | 2.57M | -62.30M | -96.03% |
Dec 31, 2020 | 64.87M | 15.23M | 30.67% |
Dec 31, 2019 | 49.65M | 33.55M | 208.38% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cosmos Health | 56.04M |
STRATA Skin Sciences | 32.68M |
Marinus Pharmaceuticals | 31.47M |
Ekso Bionics Holdings | 17.68M |
Aspira Women's Health | 8.96M |
Kazia Therapeutics | 1.66M |
Eterna Therapeutics | 598.00K |
AIM ImmunoTech | 190.00K |
TXMD News
- 5 weeks ago - TherapeuticsMD Announces Third Quarter 2024 Financial Results - Business Wire
- 4 months ago - TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying - Benzinga
- 4 months ago - TherapeuticsMD Announces Second Quarter 2024 Financial Results - Business Wire
- 8 months ago - TherapeuticsMD Announces First Quarter 2024 Financial Results - Business Wire
- 9 months ago - TherapeuticsMD Announces Full Year 2023 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD Announces Third Quarter 2023 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD Announces Second Quarter 2023 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD: From Fallen And Forgotten To Cash Cow - Seeking Alpha